“Telbivudine (Sebivo) in Patients With Hepatitis B Virus (HBV) Chronic Infection”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 9, no. 4, Jan. 2008, pp. 215-8, https://doi.org/10.7175/fe.v9i4.238.